Zealand Pharma to participate in Jefferies Virtual Healthcare Conference
Company announcement – No. 32/ 2021 Zealand Pharma to participate in Jefferies Virtual Healthcare Conference Copenhagen, DK and Boston, MA, U.S.…
Pharmaceuticals, Biotechnology and Life Sciences
Company announcement – No. 32/ 2021 Zealand Pharma to participate in Jefferies Virtual Healthcare Conference Copenhagen, DK and Boston, MA, U.S.…
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article…
– Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021 – Basking Ridge, N.J., May…
BALA CYNWYD, Pa., May 25, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…
BRIDGEWATER, N.J., May 25, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated…
AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and…
Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment…
LEXINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,…
CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR or the Company), a cell therapy company pioneering…
BURLINGAME, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that…